The Food and Drug Administration put guidelines in place to curb the amount of lead in baby food, but some like one Illinois ...
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...
In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about ...
The biotherapeutics company said the treatment, LYT-200, is being evaluated in two ongoing clinical trials. It was previously granted orphan drug designation for the treatment of acute myeloid ...
Johnson & Johnson has won Food and Drug Administration priority review for its application seeking approval of nipocalimab in certain patients with generalized myasthenia gravis.
Johnson & Johnson (NYSE: JNJ) today announced the nipocalimab Biologics License Application (BLA) received Priority Review designation from the U.S Food and Drug Administration (FDA) for the treatment ...
These granules, available in 25 mg, 50 mg, and 75 mg per unit dose packets, are a generic equivalent of Kalydeco Oral ...
There's an urgent push underway to get the U.S. Food and Drug Administration to finally ban the devices that administer ...
The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were ...
The US Food and Drug Administration (FDA) has announced a final rule expanding the approval pathway for nonprescription drug ...
Express US takes a look at the products which have been recalled by the Food and Drug Administration since the start of ...
Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.